MediBloc (MED) Price Prediction

Deep Dive

1. Project-specific catalysts

• Token swaps (latest: 9th swap on 1 June 2025) consolidate supply but historically show minimal price impact. These biannual events primarily migrate legacy tokens to the mainnet, avoiding dilution.
• New business initiatives like K-Beauty medical partnerships (announced January 2024) could drive MED utility if user adoption materializes. However, the 500M MED liquidation for tax/business expansion (Q1 2024) increased circulating supply by 6%, creating persistent sell-side pressure.

2. Technical outlook

• Bearish momentum: Price ($0.00577) trades below all key SMAs (7-day SMA: $0.0061; 200-day SMA: $0.0073). MACD histogram (-0.000061) confirms downward acceleration.
• Oversold signal: 7-day RSI at 26.3 (30 = oversold threshold) suggests possible near-term bounce, but 21-day RSI (39.96) remains neutral.
• Critical resistance: Fibonacci 23.6% level at $0.0069 – a break above could target $0.0073 (200-day SMA).

3. Market & competitive landscape

• Altcoin headwinds: The Altcoin Season Index sits at 38/100 (2 August 2025), signaling capital rotation away from small caps like MED. Bitcoin dominance (+61.17%) compounds pressure.
• Low liquidity risk: MED’s turnover ratio (volume/market cap) is 0.0192, indicating thin markets prone to volatility.

Conclusion

MED’s trajectory hinges on reversing technical weakness while navigating altcoin-sector outflows and digesting past supply inflation. Strategic healthcare partnerships could offset bearish momentum if adoption metrics improve. Will MED’s oversold RSI trigger a relief rally, or will macro headwinds extend the -20.97% 90-day decline?